Nanobiotix Files 6-K for November 2025
Ticker: NBTX · Form: 6-K · Filed: Nov 12, 2025 · CIK: 1760854
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
TL;DR
Nanobiotix filed a 6-K, confirming 20-F annual report filings.
AI Summary
Nanobiotix S.A. filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, a foreign private issuer, is based in Paris, France, and operates in the pharmaceutical preparations sector. This filing indicates they will file their annual reports under cover of Form 20-F.
Why It Matters
This filing is a routine report for foreign private issuers, providing updates to the SEC and investors about the company's ongoing activities and reporting structure.
Risk Assessment
Risk Level: low — This is a standard, routine filing for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the Form 6-K
- Paris, France (location) — Principal executive office location
- 20251112 (date) — Filing date of the report
- November 2025 (date) — Reporting period
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What does Nanobiotix S.A. do?
Nanobiotix S.A. is listed under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
When was this Form 6-K filed?
This Form 6-K was filed on November 12, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
Does Nanobiotix S.A. file annual reports under Form 20-F?
Yes, the filing indicates with a checkmark that Nanobiotix S.A. files or will file annual reports under cover of Form 20-F.
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 9.1 · Accepted 2025-11-12 06:30:04
Filing Documents
- f6k_111025.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 5KB
- 0001171843-25-007215.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nanobiotix S.A. (Registrant) Date: November 11, 2025 /s/ Bart Van Rhijn Bart Van Rhijn Chief Financial Officer